Clinical trial
Peginterferon and Ribavirin on Virologic and Immunologic Parameters in Hepatitis…
NCT00150904 · UMC Utrecht, Other · Completed
Key facts
| NCT number | NCT00150904 |
|---|---|
| Title | Peginterferon and Ribavirin on Virologic and Immunologic Parameters in Hepatitis C Mono- and Coinfected Patient (PRIVICOP) |
| Official title | Request for Blood Samples to Examine the Effect of Peginterferon and Ribavirin on Virologic and Immunologic Parameters in Patients With Hepatitis C and in Patients Coinfected With Hepatitis C and HIV |
| Lead sponsor | UMC Utrecht, Other |
| Collaborators | Hoffmann-La Roche Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Hepatitis C, HIV Infections |
| Intervention type | Procedure |
| Interventions | venous blood puncture |
| Enrollment | 28 |
| Start date | Aug 1, 2005 |
| Primary completion | Sep 1, 2008 |
| Completion | Jan 1, 2009 |
| First posted | Sep 8, 2005 |
| Last update posted | Feb 16, 2009 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: